Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Polycythemia Vera × Cytarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 146 Leukemia 77 Precursor Cell Lymphoblastic Leukemia-Lymphoma 61 Lymphoma 46 Myelodysplastic Syndromes 31 Congenital Abnormalities 29 Burkitt Lymphoma 24 Lymphoma, Non-Hodgkin 23 Leukemia, Monocytic, Acute 23 Leukemia, Myelomonocytic, Acute 22 Recurrence 21 Leukemia, Erythroblastic, Acute 21 Lymphoma, Mantle-Cell 20 Leukemia, Megakaryoblastic, Acute 19 Hodgkin Disease 18 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma, Follicular 12 Myeloproliferative Disorders 11 Leukemia, Myelomonocytic, Chronic 11 Leukemia, Biphenotypic, Acute 10 Leukemia, Eosinophilic, Acute 8 Blast Crisis 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasms 7 Multiple Myeloma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Anemia, Refractory, with Excess of Blasts 7 Leukemia, Lymphocytic, Chronic, B-Cell 6 Leukemia, Basophilic, Acute 6 Hematologic Neoplasms 6

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 ruxolitinib 8 Busulfan 8 Cyclophosphamide 7 Tacrolimus 6 fludarabine 5 Melphalan 5 Cyclosporine 5 Methotrexate 4 Antilymphocyte Serum 4 givinostat hydrochloride 3 givinostat 3 Lenalidomide 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 thymoglobulin 2 pomalidomide 2 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Prednisone 2 Hydroxyurea 2 Etoposide 2 Dasatinib 2 Carboplatin 2 veliparib 1 sonidegib 1 pembrolizumab 1 peginterferon alfa-2a 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡